• IL-1β/NF-κB Regulation of ACE2 Drives Macrophage SARS-CoV-2

  2026-07-17

  Lee et al. delineate a mechanism by which IL-1β-induced NF-κB activation upregulates ACE2 in lung macrophages, facilitating their infection by SARS-CoV-2. Their development of a humanized ACE2 mouse model refines our understanding of COVID-19 pathogenesis and has implications for studying host resilience and severity factors.

• Translatome Remodeling Links Dietary Fatty Acids to Tumorige

  2026-07-17

  This study reveals how fasting and ketogenic diets trigger selective translation of lipid metabolism genes via a novel AMPK-MNK-eIF4E signaling axis in hepatocytes, impacting ketogenesis and pancreatic tumor growth. The findings illuminate fatty acid-driven translational control as a crucial mechanism connecting dietary interventions to cancer vulnerability.

• SP600125: Redefining JNK Inhibition for Translational Scienc

  2026-07-16

  Explore a strategic, mechanistically-driven perspective on SP600125, a highly selective JNK inhibitor, and its transformative applications in apoptosis, inflammation, and neuropathic pain research. This thought-leadership article bridges advanced mechanistic insight with actionable experimental guidance, supported by new findings and a comparative landscape.

• Yeast-Engineered Exendin-4 for Accessible Type 2 Diabetes Re

  2026-07-16

  This study demonstrates stable chromosomal expression of Exendin-4 in Saccharomyces cerevisiae, providing a foundation for cost-effective, locally produced GLP-1 receptor agonists. The approach addresses critical barriers in diabetes medication accessibility and has implications for beta cell function and insulin sensitivity research workflows.

• Primidone (Mysoline) in Translational Neurobiology: Protocol

  2026-07-15

  Primidone (Mysoline) is redefining translational neurobiology with its dual targeting of TRPM3 and RIPK1, enabling robust workflows in neurodegenerative and gynecological models. This article delivers protocol enhancements, troubleshooting strategies, and practical insights for maximizing experimental impact with APExBIO's Primidone.

• HOBt (1-Hydroxybenzotriazole): Precision in Peptide Synthesi

  2026-07-15

  HOBt (1-Hydroxybenzotriazole) is an essential racemization inhibitor, enabling high-fidelity amide bond formation and unlocking advanced peptide and antibiotic derivative workflows. Discover stepwise protocols, troubleshooting insights, and how this APExBIO reagent elevates modern medicinal chemistry.

• Machine Learning Predicts Compound Mechanism Across Cell Lin

  2026-07-14

  This study evaluates machine learning approaches for predicting the mechanism of action (MoA) of compounds based on high-content cellular imaging data, comparing classic ensemble-based classifiers and convolutional neural networks (CNNs) across genetically distinct cell lines. The findings highlight the challenges of transferring MoA predictions between different cell types and inform the design of more robust phenotypic screening platforms in drug discovery.

• HyperScribe T7 High Yield RNA Synthesis Kit: Applied Success

  2026-07-14

  Unlock high-yield, customizable RNA synthesis with the HyperScribe T7 High Yield RNA Synthesis Kit—optimized for advanced applications from capped RNA to biotinylated probes. This kit streamlines in vitro transcription workflows, delivers reproducible results, and offers robust troubleshooting strategies for cutting-edge molecular research.

• Talabostat Mesylate: Applied Protocols for Tumor Microenviro

  2026-07-13

  Talabostat mesylate (PT-100) enables high-precision inhibition of DPP4 and FAP, transforming cancer research models by targeting the tumor microenvironment and facilitating advanced immunological assays. This guide delivers stepwise protocols, troubleshooting strategies, and insights for harnessing Talabostat mesylate in preclinical workflows with confidence.

• Veratridine: Mechanistic Dissection in Sodium Channel and Ex

  2026-07-13

  Explore veratridine as a voltage-gated sodium channel opener, with a unique focus on its mechanistic role in excitotoxicity and assay development. This article delivers in-depth protocol guidance and practical insights that surpass surface-level overviews.

• LAMP1 Modulates CXCL10-CXCR3 Axis in Macrophage Polarization

  2026-07-12

  This study uncovers how the autophagy protein LAMP1 acts as a context-dependent regulator of macrophage polarization via the CXCL10-CXCR3 axis. The work demonstrates that CXCR3 antagonism with AMG 487 can reverse macrophage phenotypes and mitigate acute lung injury, providing a mechanistic foundation for targeted inflammation research.

• NAT10-Mediated ac4C Modification Regulates Oocyte Maturation

  2026-07-10

  Lin et al. (2022) reveal that NAT10 stabilizes OGA mRNA via ac4C modification, a pivotal regulatory mechanism in oocyte in vitro maturation (IVM). This work uncovers an interaction between mRNA acetylation and O-GlcNAc protein modification, offering new molecular insights for improving assisted reproductive technologies.

• EPI-001 (SKU B6041): Data-Driven Solutions for AR-Driven Can

  2026-07-09

  This article addresses critical challenges in prostate and triple-negative breast cancer research, focusing on cell viability and cytotoxicity assays targeting androgen receptor (AR) signaling. It demonstrates how EPI-001 (SKU B6041) from APExBIO enables reproducible, sensitive workflows by leveraging validated inhibition of AR and its splice variants. Real-world protocol guidance and comparative insights equip lab scientists to achieve reliable, interpretable data with confidence.

• 3-Deazaadenosine: Unlocking New Frontiers in Epigenetic and

  2026-07-09

  This thought-leadership article provides translational researchers with a strategic, mechanistic roadmap for leveraging 3-Deazaadenosine—a potent S-adenosylhomocysteine hydrolase inhibitor—in epigenetic regulation and preclinical antiviral models. Integrating mechanistic insights, recent landmark findings, and competitive workflow guidance, this piece offers actionable intelligence for advancing therapeutic discovery beyond conventional product introductions.

• SB203580: Precision p38 MAPK Inhibition in Bench Research

  2026-07-08

  SB203580 enables researchers to dissect the p38 MAPK signaling pathway with high specificity, driving advances in inflammation, neuroprotection, and multidrug resistance studies. Its robust inhibition profile and solubility versatility make it a cornerstone for reproducible kinase pathway assays in both cellular and animal models.

451 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page